The worldwide rise of antibiotic-resistant bacterial strains has created the need for alternative means of controlling pathogenic bacteria[@b1]. Recently, interest in bacteriophages has increased because of their potential use as typing, diagnostic, therapeutic, decontaminating and bio-control agents[@b2][@b3]. In this study, *Achromobacter xylosoxidans* phage phiAxp-1 was isolated and characterized biologically. *A. xylosoxidans* is an aerobic Gram-negative bacillus that is an opportunistic human pathogen of immunocompromised hosts[@b4]. As a motile bacterium from the *Achromobacter* genus of the *Alcaligenaceae* family[@b5], it is mainly found in moist soil and different water sources[@b6]. Recently, *A. xylosoxidans* was recognized as an emerging nosocomial pathogen[@b7]. This bacterium is commonly associated with a range of respiratory infections[@b8]. Although a large diversity of phages targeting a broad range of *A. xylosoxidans* strains have been described[@b6], only two phages, JWAlpha and JWDelta, have been studied in detail via whole genome sequencing[@b7]. Our research aimed to isolate and characterize novel *Achromobacter* phages to expand the repertoire of phages available for targeting clinically significant *A. xylosoxidans*. Genomic analysis of bacteriophages is an important preliminary step in the development of a phage therapy protocol[@b9]. In this manuscript, we sequenced the genome of phage phiAxp-1 and characterized it further by transmission electron microscopy (TEM), and one-step growth curve and stability studies. In addition, the host component bound by the phage was identified.

Results and Discussion
======================

Morphology
----------

Phage phiAxp-1 was purified successfully from a lysed lawn of the host bacteria *A. xylosoxidans* A22732. *A. xylosoxidans* strain A22732 harbours a conjugative imipenem-encoding plasmid and is resistant to multiple β-lactam antibiotics, including imipenem and meropenem[@b5]. Purified phages were negatively stained and examined by TEM ([Fig. 1a](#f1){ref-type="fig"}). The head is approximately 66 nm in diameter. The phage particles are each associated with a long non-contractile tail of approximately 230 nm in length and 15 nm in width. Collectively, these morphological features indicated that this virus belongs to the family *Siphoviridae*. The phage produced large, clear, round plaques of 2--3 mm in diameter on a lawn of *A. xylosoxidans* A22732 ([Fig. 1b](#f1){ref-type="fig"}). Multiplication parameters of phage phiAxp-1 were determined under one-step growth curve conditions ([Fig. 1c](#f1){ref-type="fig"}). The latent period, defined as the time interval between adsorption and the beginning of the first burst, was about 75 min. The burst time of 90 min and the average burst size of 1,742 pfu/cell were determined, calculated as the ratio of the final count of liberated phage particles to the initial count of infected bacterial cells during the latent period. Host range tests suggested that phiAxp-1 was virulent specifically to only five strains of *A. xylosoxidans* strains among all species tested (n = 57) ([Table 1](#t1){ref-type="table"}). Besides the reported multidrug-resistant strain A22732, all the other four clinical *A. xylosoxidans* strains were determined to be resistant to aztreonam and tobramycin.

General features of the phiAxp-1 genome
---------------------------------------

The DNA sequence of phage phiAxp-1 is a circular double stranded DNA of 45,045 bp with a GC content of 56.02%. The genome contains 64 putative open reading frames (ORFs); however, only 21 ORFs share similarity at the protein level with other sequences deposited in GenBank. The predicted phiAxp-1 ORFs are between 30 and 1331 codons in length. Fifty-five (86%) of the phiAxp-1 genes are transcribed in one direction, designated as rightward on the genome map ([Fig. 2](#f2){ref-type="fig"}), and nine genes are transcribed in the leftward direction. The GC content is approximately the same for both sets of ORFs. Fifty-eight of the 64 predicted ORFs start with an ATG codon, four ORFs use TTG, and two use GTG. At the ends of phiAxp-1 genes, there are 30 TAA stop codons, 30 TGA codons, three TAG codons and one AAA codon. Although we propose that phiAxp-1 is a siphovirus, the proteins of the phage have largely uncharacterized functions. Putative functional gene assignments included a large terminase subunit, capsid and tail genes, and DNA replication/modification/salvage genes. The phiAxp-1 genome has a modular organization, which is common among phages[@b10]. The proteins encoded by phiAxp-1 belong to four different functional categories: virion morphogenesis (including capsid and tail morphogenesis), DNA packaging, DNA replication, and MazG (a pyrophosphohydrolase[@b11]). Putative functional assignments and significant similarities to other sequences are listed in [Table 2](#t2){ref-type="table"}. The proteins with assigned functions share weak homology with proteins found in other dsDNA bacteriophages, infecting diverse hosts, such as *Burkholderia* phage KL1, *Pseudomonas* phage 73, *Pseudomonas* phage vB_Pae-Kakheti25, *Pseudomonas* phage vB_PaeS_SCH_Ab26, *Acinetobacter* phage IME_AB3 and *Achromobacter* phage JWX, with percent identities of 24--70%. Multiple genome alignments showed the weak homology of phiAxp-1 with these phages at the whole genome level ([Fig. 3](#f3){ref-type="fig"}). In addition, 18 virion proteins were detected using liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS), of which 12 have been assigned putative functions ([Table 3](#t3){ref-type="table"}).

Of the 21 phiAxp-1 proteins with a suggested function, half of them are structural and morphogenesis proteins. Based on BLASTP analysis, the capsid morphogenesis and DNA packaging module contains genes encoding the large terminase subunit, capsid and tail proteins ([Fig. 2](#f2){ref-type="fig"}). As a phage with *Siphoviral* morphotypes, the genes for head and tail assembly are arranged together, with the head genes 5′ to the tail genes[@b12]. Terminase genes are involved in initiation of DNA synthesis and are responsible for the packaging of the concatameric DNA in phage capsids[@b13]. *gp40* (terminase large subunit) shares similarity with the terminase large subunit protein from KL1 (70% identity), vB_PaeS_SCH_Ab26 (66% identity) and 73 (67% identity). Phylogenetic analysis of the available bacteriophage terminase proteins also demonstrated that phiAxp-1 could not be assigned to a branch ([Fig. 4](#f4){ref-type="fig"}). Portal proteins are responsible for forming a ring that enables DNA to pass into the major capsid during assembly and out during infection, serving as a junction between the capsid and tail proteins[@b13][@b14]. *gp41* encodes a protein similar to the portal proteins found in the genomes of vB_Pae-Kakheti25 (48% identity), vB_PaeS_SCH_Ab26 (48% identity) and 73 (48% identity). *gp42* (head morphogenesis protein) shares weaker identity with the head morphogenesis protein from KL1 (28% identity). *gp43* (scaffold protein) is similar to vB_PaeS_SCH_Ab26 orf9 (46% identity), and *gp44* (major capsid protein) is similar to the major capsid protein of IME_AB3 (54% identity). The phiAxp-1 genome encodes six putative tail proteins, including a minor tail protein (*gp48*), a major tail tube protein (*gp49*), two tail chaperonin proteins (*gp50--51*), a tail tape measure protein (*gp53*) and a tail component protein (*gp59*) ([Table 2](#t2){ref-type="table"}). The tail tape measure protein (1044 amino acids \[aa\], encoded by *gp53*) is similar to the predicted KL1 tape measure protein orf21 (41% identity). The tape measure protein is important for the assembly of phage tails and is involved in tail length determination[@b15][@b16]. Importantly, the largest protein encoded by phiAxp-1 is the tail component protein (*gp59*, 1331 aa) rather than the tail tape measure protein, which is commonly the largest protein of siphovirus[@b12]. In addition, gp57--59 are similar to JWX orf25--27 (42--50% identity).

phiAxp-1 encodes a cluster of proteins involved in DNA replication. These DNA- or nucleotide binding proteins include DNA polymerase (*gp62*), DNA polymerase III β subunit (*gp63*), DNA/RNA helicase (*gp2*), single-stranded DNA-binding protein (*gp3*), recombinase (*gp4*), replicative primase/helicase (*gp8*) and exonuclease (*gp28*) ([Fig. 2](#f2){ref-type="fig"}). *gp62* (DNA polymerase) and *gp63* (DNA polymerase III β subunit) are similar to those of IME_AB3 (55% identity) and vB_PmaS_IMEP1 (33% identity), respectively, and are thought to be responsible for genome replication. *gp33* (deoxycytidylate deaminase) is similar to *Thermus* phage TMA orf38 (46% identity) and is involved in nucleotide salvage. A notable protein encoded by phiAxp-1 is MazG, which is a pyrophosphohydrolase that acts on ppGpp, one of the signalling molecules produced by bacteria during the stringent response[@b9]. The *mazG* gene provides a significant selective advantage to phages[@b17]. The putative MazG protein is encoded by phiAxp-1 *gp6* and contains a MazG nucleotide pyrophosphohydrolase domain and is similar to the putative MazG protein from phage IME_AB3 (37% identity).

Stability studies
-----------------

Stability studies of phage phiAxp-1 were conducted with different pHs, disinfectants, temperatures and ions, using a temperature-controlled incubator or water baths. The results are summarized in [Fig. 5](#f5){ref-type="fig"}. The phage was most stable at pH 7, there was a significant reduction in the phage titre either above or below pH 7; the phage titre was further decreased under extremely acidic (pH 4) or basic (pH 12) conditions ([Fig. 5a](#f5){ref-type="fig"}). No significant loss of phage titre was observed from 4 to 37  °C. However, the phage titre dramatically decreased when the temperature is over 50 °C ([Fig. 5b](#f5){ref-type="fig"}). The activities of phage phiAxp-1 were affected in the presence of ethanol ([Fig. 5c](#f5){ref-type="fig"}), the phage was resistant to isopropanol ([Fig. 5d](#f5){ref-type="fig"}) at low concentrations (10%, v/v), whereas it became unstable with increasing concentrations: there was a significant reduction in phage titre at high concentration (95%, v/v). Many phages require divalent ions such as Ca^2+^ or Mg^2+^ for attachment or intracellular growth[@b18]. It may be necessary to treat phages with Ca^2+^ or Mg^2+^ to obtain an efficient phage infection. The effects of divalent ions on phage amplification were evaluated and the phage revealed divalent cation dependency for optimal infectivity. Divalent cations at no more than 20 mM were beneficial for plaque development ([Fig. 5e](#f5){ref-type="fig"}).

Identification of the phage receptor
------------------------------------

In Gram-negative bacteria, outer membrane proteins or lipopolysaccharide (LPS) may function as specific phage receptors[@b19]. Therefore, it was necessary to test whether the degradation of cell surface proteins or LPS could inhibit phiAxp-1 binding[@b20]. *A. xylosoxidans* cells were treated with either proteinase K (to destroy surface proteins) or periodate (to destroy surface carbohydrates) before the phage adsorption assay to determine the possible nature of the phage receptor[@b20]. phiAxp-1 exhibited high infection efficiency when mixed with untreated and proteinase K-treated *A. xylosoxidans* cells ([Fig. 6a](#f6){ref-type="fig"}): the majority of the phages were removed from the suspension after centrifugation by binding to *A. xylosoxidans* cells. This suggested that the functional receptor is not a protein. The broad substrate specificity of proteinase K meant that the possibility that the receptor is a protein resistant to proteinase K is unlikely[@b19]. When the phage was incubated with periodate-treated *A. xylosoxidans*, the majority of the phages remained in the supernatant ([Fig. 6b](#f6){ref-type="fig"}). The significant increase of free phage particles suggested that the phages were unable to efficiently adsorb onto the periodate-treated bacteria. Therefore, the *A. xylosoxidans* receptor recognized and bound by phiAxp-1 is a carbohydrate structure, most likely LPS. Significant inactivation of phages was further confirmed using LPS purified from *A. xylosoxidans*, which demonstrated LPS is the adsorption target (receptor) of this phage ([Fig. 7](#f7){ref-type="fig"}). The results revealed direct correlation between *A. xylosoxidans* LPS concentration and phage infectivity inhibition, and 12.5 μg/ml of LPS was sufficient to inhibit the binding activity of 50% of 4.7 × 10^4^ pfu phiAxp-1. LPS of *Escherichia coli* 0111:B4 was used as a negative control. As shown in [Fig. 7](#f7){ref-type="fig"}, *E. coli* LPS showed no phage inactivating ability compared with that from *A. xylosoxidans* LPS, thus indicating that LPS from *A. xylosoxidans* is specific for phage phiAxp-1. In this respect, it is consistent with the features of most phages with Gram-negative bacterial hosts.

Concluding Remarks
==================

The clinical relevance of nosocomially-acquired infections caused by multi-resistant *Achromobacter* strains is increasing rapidly, becoming a critical problem[@b7]. Phages are re-emerging as promising potential therapies for the treatment of bacterial infections[@b21]. Here, we report a preliminary analysis of *A. xylosoxidans* bacteriophage phiAxp-1. This article presents the sequence analysis and a detailed genome annotation of phage phiAxp-1. The genomic data constitute an important resource to study and engineer phages to control specific bacterial species[@b22]. The analysis showed that phiAxp-1 does not easily fit into previously established groups of dsDNA bacterial viruses and may represent a distinct branch of the *Siphoviridae* family.

Stability is the primary requirement for any possible commercial use of the phage, which can reduce the cost of storage significantly[@b23]. Therefore, in this study, the stability tests on phage phiAxp-1 under different pHs, temperatures, disinfectants and ions were performed for the potential practical application of phiAxp-1. Despite its importance, the molecular interactions between phiAxp-1 and the surface of *A. xylosoxidans* are still poorly understood. Phages bind to unique host-specific structures, allowing them to recognize a suitable host in a mixed bacterial population[@b24]. In this study, periodate treatment of *A. xylosoxidans*, but not proteinase K treatment, inhibited phage binding. Furthermore, purified LPS from the *A. xylosoxidans* showed phage-inactivating capacities thus confirmed that LPS of *A. xylosoxidans* is the receptor of phage phiAxp-1.

The emergence of phage-resistant mutants affecting phage receptors is a major concern regarding the use of phage therapy[@b25]. The LPS of Gram-negative bacteria commonly represents an important virulence factor and is of great significance in the pathophysiology of many disease processes[@b26]. Thus, the phage-resistant mutants resulting from the loss or alteration of the receptor will be avirulent or attenuated. Such mutants do not pose a problem during bacteriophage treatment[@b25]. Our future work will explore this possibility. These results suggest that phage phiAxp-1 is a promising candidate for controlling *A. xylosoxidans* and represents an advance in our current knowledge of *A. xylosoxidans* phages.

Methods
=======

Bacterial strains and growth media
----------------------------------

Luria-Bertani (LB) broth medium was used to grow the bacterial strains and to propagate the phage. *A. xylosoxidans* strain A22732 was used as the indicator strain for phage isolation.

Isolation of phage and host range determination
-----------------------------------------------

phiAxp-1 was isolated from a water sample of the Bohai sea of China using a double agar overlay plaque assay, as described previously for the isolation of lytic phages[@b27]. The water sample was centrifuged at 8,000 × *g* for 10 min to remove the solid impurities. The supernatants were filtered through a 0.22-μm pore-size membrane filter to remove bacterial debris. The filtrates were then mixed with *A. xylosoxidans* culture to enrich the phage at 37 °C. The culture was centrifuged, and the supernatant was filtered through a 0.22-μm pore-size membrane to remove the residual bacterial cells. Aliquots of the diluted filtrate were mixed with *A. xylosoxidans* culture. Then, 3 mL of molten top soft nutrient agar (0.7% agar) were overlaid on the solidified base nutrient agar (1.5% agar)[@b28]. Following incubation for 10 h at 37 °C, clear phage plaques were picked from the plate. The phage titre was determined using the double-layered method. The host range of the phage was tested against 57 clinical strains from our microorganism centre, as determined by standard spot tests[@b29]. Briefly, 10 μl from a purified phage suspension containing approximately 10^8^ pfu/mL were spotted in the middle of a lawn of bacteria and left to dry before incubation overnight. Bacterial sensitivity to a bacteriophage was established by bacterial lysis at the spot where the phage was deposited. Each strain was tested three times at 37 °C.

TEM
---

To prepare phiAxp-1 for transmission electron microscopy studies, cell debris from 500 mL of *A. xylosoxidans* strain A22732 infected with phiAxp-1 was pelleted by centrifugation. Phage particles were precipitated with 1 M NaCl and 10% polyethylene glycol (PEG) 8000 at 4 °C with stirring for 60 min. The precipitated phage particles were harvested. Phage particles were resuspended in Saline - magnesium (SM) diluent plus gelatin (SMG) (50 mM Tris-HCl \[pH 7.5\] containing 100 mM NaCl, 8.1 mM MgSO~4~ and 0.01% (w/v) gelatin) and extracted with an equal volume of chloroform. After low-speed centrifugation, the aqueous phase was sedimented at about 25,000 × g for 60 min. Phage particles were negatively stained with 2% (wt/vol) phosphotungstic acid (pH 7), air dried, and examined under a Philips EM 300 electron microscope operated at 80 kV and 120 KEv.

One-step growth curve
---------------------

One-step growth experiments were performed as described previously[@b30]. Host strain *A. xylosoxidans* strain A22732 cells were harvested at exponential growth and resuspended in LB. The phage phiAxp-1 was added at a multiplicity of infection (MOI) of 0.0005 and allowed to adsorb for 5 min at room temperature. The mixture was centrifuged and the pellets containing infected cells were suspended in 10 ml of LB, followed by incubation at 37 °C. Samples were taken at 10 min intervals (up to 110 min) and immediately diluted, and then titres were determined by the double-layered-agar plate method.

Stability studies
-----------------

A temperature-controlled incubator or water bath was used to determine the stabilities at different pH, disinfectants, ions or temperatures. After the desired treatment, the tube was cooled down slowly, placed in an ice water bath and samples were assayed to determine surviving pfu. Briefly, for thermal stability tests, aliquots of phage suspensions were incubated at 37 °C (pH 1--14) for 60 min, and then the phage titres were tested by the double-layer agar method. For pH stability tests, aliquots of phage suspensions were incubated at 4, 25, 37, 50, 60, 70 and 80 °C for 75 min; the phage titres were determined every 15 min. For disinfectant sensitivity, aliquots of phage suspensions were incubated with different concentrations of ethanol or isopropanol for 90 min; the phage titres were determined every 30 min. For divalent ion sensitivity, aliquots of phage suspensions were assayed on solidified base nutrient agar (1.5% agar) with different concentrations of Mg^2+^ or Ca^2+^ and the phage titres were tested.

Isolation of phage DNA, genome sequencing and assembly
------------------------------------------------------

phiAxp-1 DNA was extracted from purified phage particles with phenol-chloroform (24:1, vol/vol) and precipitated with 100% ethanol. The samples were visualized on 0.7--1.0% agarose gels, and the purified phage DNA was sequenced using an Illumina HiSeq2500 sequencer. The sequence reads were filtered to remove low quality sequences, trimmed to remove adaptor sequences and the filtered sequences were assembled. The final assembled sequence was searched against the current protein and nucleotide databases ( <http://www.ncbi.nlm.nih.gov/>) using Basic Local Alignment Search Tool (BLAST) software[@b31]. BLASTP was used to determine the similarity to described proteins in the National Center for Biotechnology Information \[NCBI\] database ( <http://www.ncbi.nlm.nih.gov>). The CLC Main Workbench, version 6.1.1 (CLC bio, Aarhus, Denmark) was used for genome annotation. Computer-based predictions were checked manually. Phylogenetic analysis with the published genome sequences of related phages was conducted using ClustalW (Slow/Accurate, IUB). Whole genome comparisons were carried out using Mauve[@b32]. LC/ESI/MS/MS spectra (Q-TOF Ultima API, Micromass UK Ltd.) were used to identify the phage proteins, as described previously[@b33].

Identification of the phage receptor
------------------------------------

Receptor properties of phiAxp-1 were determined as described previously[@b19]. Briefly, *A. xylosoxidans* A22732 cultures were treated with sodium acetate (50 mM, pH 5.2) containing 100 mM IO^4−^ at room temperature for 2 h (protected from light) or proteinase K (0.2 mg/ml; Promega) at 37 °C for 3 h to determine whether proteinase K or periodate can destroy the phage receptor. The phage adsorption assay was then performed as previously described[@b20]. LB was used as a non-adsorbing control in each assay, and the phage titre in the control supernatant was set to 100%. Each assay was performed in duplicate and repeated twice[@b19].

Phage inactivation by LPS
-------------------------

LPS extraction from *A. xylosoxidans* was performed using an LPS extraction kit from Intron Biotechnology (17144; Boca Scientific, Boca Raton, FL, USA), according to the manufacturer's instructions. LPS from *Escherichia coli* O111:B4 purchased from Sigma-Aldrich, Inc. (L2630; Sigma, USA) was used as a negative control to ensure that the possible effect was specific to *A. xylosoxidans* LPS. Both LPS of *Escherichia coli* O111:B4 and *A. xylosoxidans* A22732 are smooth type. The phage inactivation by LPS was performed as previously described[@b34].

### Nucleotide sequence accession number

The annotated genome sequence for the phage phiAxp-1 was deposited in the NCBI nucleotide database under the accession number KP313532.
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![Isolated Achromobacter phage phiAxp-1.\
(**a**) Morphology of the bacteriophage. Transmission electron micrograph (TEM) of phage phiAxp-1 at ×120000. The phages were negatively stained with 2% uranyl-acetate. The bar indicates 100 nm. (**b**) Plaques of phage phiAxp-1 between 2 and 3 mm in diameter on *A. xylosoxidans* strain A22732. (**c**) One-step growth curve of the bacteriophage. Phages were grown in an exponential phase culture of *A. xylosoxidans* strain A22732. Shown are the PFU per infected cell in cultures at different time points. Each data point is the mean from three experiments.](srep21943-f1){#f1}

![Genomic map of phiAxp-1.\
The genome map of phiAxp-1 was drawn using CLC Main Workbench, version 6.1.1 (CLC bio, Aarhus, Denmark). The bacteriophage phiAxp-1 genome is presented schematically with predicted open reading frames (ORFs) indicated by arrows; the direction of the arrow represents the direction of transcription.](srep21943-f2){#f2}

![Multiple genome alignment performed using Mauve software ([http://asap.ahabs.wisc.edu/mauve/](http://)) and the chromosomes of related phages.\
Similarity is represented by the height of the bars, which correspond to the average level of conservation in that region of the genome sequence. Completely white regions represent fragments that were not aligned or contained sequence elements specific to a particular genome. Boxes with identical colours represent local collinear blocks (LCB), indicating homologous DNA regions shared by two or more chromosomes without sequence rearrangements. LCBs indicated below the horizontal black line represent the reverse complements of the reference LCB.](srep21943-f3){#f3}

![Phylogenetic tree based on large terminase subunits of selected bacteriophages.\
The large terminase subunits were compared using the ClustalW program, and the phylogenetic tree was generated using the neighbour-joining method and 1000 bootstrap replicates.](srep21943-f4){#f4}

![Stability of phage phiAxp-1 under different pHs (**a**), temperatures (**b**), ethanol concentrations (**c**), isopropanol concentrations (**d**) and divalent ion concentrations (**e**). The results were expressed as a percentage of the initial viral counts. Each assay was performed as three repetitions and the values represented are the means.](srep21943-f5){#f5}

![Effects of different treatments of bacteria on phiAxp-1 adsorption.\
The results are shown as residual PFU percentages. (**A**) Effect of proteinase K treatment on the adsorption of phiAxp-1 to *A. xylosoxidans* strain A22732. (**B**) Effect of periodate treatment on the adsorption of phiAxp-1 to *A. xylosoxidans* strain A22732. The control (LB and "A22732 + acetate"), untreated strain (A22732), and treatment ("A22732 + ProtK" for proteinase K treatment and "A22732 + IO^4−^" for periodate treatment) groups were tested for adsorption, as indicated in the *x-*axes. Error bars denote statistical variations. Significance was determined by a Student's *t* test for comparison between the treated and the untreated groups. \**P* 0.05.](srep21943-f6){#f6}

![Inactivation of phiAxp-1 by lipopolysaccharide (LPS) derived from *A. xylosoxidans* A22732.\
% Infectivity was determined after 1 hr of incubation at 37 °C. Error bars denote statistical variations.](srep21943-f7){#f7}

###### Host range infection of the phage phiAxp-1.

  Species                                ID         Infection
  -------------------------------- --------------- -----------
  *Achromobacter xylosoxidans*         A22732          \+
  *A. xylosoxidans*                     5271           \+
  *A. xylosoxidans*                      844           \+
  *A. xylosoxidans*                   201308881        \+
  *A. xylosoxidans*                     6065           \+
  *Enterobacter aerogenes*              3-SP            −
  *E. aerogenes*                      201316724         −
  *E. aerogenes*                      2015--301         −
  *E. aerogenes*                        13208           −
  *E. aerogenes*                       A29864           −
  *E. aerogenes*                       A36179           −
  *E. aerogenes*                        AH10            −
  *E. aerogenes*                        AH12            −
  *E. aerogenes*                        AH13            −
  *E. aerogenes*                        AH14            −
  *E. aerogenes*                        AH15            −
  *E. aerogenes*                        AH17            −
  *E. aerogenes*                        AH18            −
  *E. aerogenes*                         AH2            −
  *E. aerogenes*                        AH20            −
  *E. aerogenes*                        AH21            −
  *E. aerogenes*                        AH22            −
  *E. aerogenes*                        AH24            −
  *E. aerogenes*                        AH25            −
  *E. aerogenes*                        AH28            −
  *E. aerogenes*                        AH29            −
  *E. aerogenes*                         AH3            −
  *E. aerogenes*                        AH30            −
  *E. aerogenes*                        AH32            −
  *E. aerogenes*                        AH33            −
  *E. aerogenes*                        AH34            −
  *E. aerogenes*                        AH36            −
  *Escherichia coli*                 ATCC 25922         −
  *E. coli*                             DH10B           −
  *E. coli*                             EC600           −
  *Klebsiella pneumoniae*           ATCC BAA-1706       −
  *K. pneumoniae*                   ATCC BAA-2146       −
  *K. pneumoniae*                   ATCC BAA-1705       −
  *K. pneumoniae*                       K2044           −
  *K. pneumoniae*                        511            −
  *Serratia marcescens*                wk2050           −
  *S. marcescens*                     201315732         −
  *S. marcescens*                       wj-1            −
  *S. marcescens*                       wj-2            −
  *S. marcescens*                       wj-3            −
  *E. cloacae*                          T5282           −
  *E. cloacae*                           TI3            −
  *E. sakazakii*                        45401           −
  *E. sakazakii*                        45402           −
  *Leclercia adcarboxglata*            P10164           −
  *Raoultella ornithinolytica*         YNKP001          −
  *Stenotrophomonas maltophilia*        9665            −
  *Citrobacter freundii*               P10159           −
  *Vibrio parahaemolyticus*             J5421           −
  *Pseudomonas aeruginosa*              PA01            −
  *Acinetobacter baumannii*              N1             −
  *Shigella sonnei*                    \#1083           −

−, absent; +, present.

###### *Achromobacter* phage phiAxp-1 gene annotations.

  Orfs     Nucleotide position   Strand   Length (aa)[a](#t2-fn1){ref-type="fn"}   Mass (Da)    pI       Best match (aa identity)     GenBank accession number   E value                      Conserved Protein Domain Family                                  Function
  ------- --------------------- -------- ---------------------------------------- ----------- ------- ------------------------------ -------------------------- --------- ------------------------------------------------------------------------ ---------------------------------
  orf01          9--266            −                        85                       9653      7.80                                                                                                                                                                 
  orf02         250--1911          −                       553                       61431     8.50         IME_AB3 gp17 (39%)               NC_023590           1e--128   cd00046; pfam00270; cd00079; smart00490; COG1061; smart00487; PRK13766      DNA/RNA helicase protein
  orf03        1979--2659          −                       226                       23634     6.76         IME_AB3 gp15 (27%)               NC_023590           2e--09                                                                                  ssDNA-binding protein
  orf04        2726--3406          −                       226                       25248     8.68          KL1 orf33 (50%)                 NC_018278           7e--67                                                                                       recombinase
  orf05        3467--3910          −                       147                       16336     7.30         IME_AB3 gp13 (32%)               NC_023590           2e--15                                                                                             
  orf06        3954--4496          −                       180                       19897     5.44         IME_AB3 gp12 (37%)               NC_023590           2e--17                         cd11541; COG1694; pfam03819                              MazG pyrophosphatase
  orf07        4623--4838          \+                       71                       8670      9.25         IME_AB3 gp10 (33%)               NC_023590           2e--04                                                                                             
  orf08        4822--7245          \+                      807                       89780     5.38    vB_PaeS_SCH_Ab26 orf35 (41%)          NC_024381             0.0                                    COG4983                                    replicative primase/helicase
  orf09        7593--8054          \+                      153                       17483     8.44                                                                                                                                                                 
  orf10        8051--8779          \+                      242                       27281     5.42                                                                                                                                                                 
  orf11        8845--9045          \+                                                                                                                                                                                                                               
  orf12        9050--9307          \+                                                                                                                                                                                                                               
  orf13        9304--9453          \+                                                                                                                                                                                                                               
  orf14        9450--9680          \+                       76                       8690      4.64                                                                                                                                                                 
  orf15        9677--10063         \+                      128                       15377     11.55                                                                                                                                                                
  orf16       10160--10390         \+                       76                       8457      8.90                                                                                                                                                                 
  orf17       10471--11160         \+                      229                       26350     9.81                                                                                                                                                                 
  orf18       11162--11461         \+                       99                       11685     9.40                                                                                                                                                                 
  orf19       11461--11901         \+                      146                       17283     10.05                                                                                                                                                                
  orf20       11911--12168         \+                       85                       9758      8.42           73 orf44 (33%)                  DQ163913            0.028                                                                                             
  orf21       12161--12370         \+                       69                       7604      7.34                                                                                                                                                                 
  orf22       12367--12765         \+                      132                       15384     6.16                                                                                                                                                                 
  orf23       12827--12946         \+                       39                       4365      7.15                                                                                                                                                                 
  orf24       12947--13039         \+                       30                       3101      8.77                                                                                                                                                                 
  orf25       13042--13254         \+                       70                       8056      7.19                                                                                                                                                                 
  orf26       13256--13579         \+                      107                       12158     9.90                                                                                                                                                                 
  orf27       13572--13781         \+                       69                       8124      4.89        CGphi29 orf59 (40%)               NC_020844           6e--04                                                                                             
  orf28       13785--14339         \+                      184                       21030     7.89         IME_AB3 gp52 (38%)               NC_023590           8e--27                                                                                      endonuclease
  orf29       14375--14695         \+                      106                       11775     8.89                                                                                                                                                                 
  orf30       14710--14892         \+                       60                       6533      10.39                                                                                                                                                                
  orf31       14889--15101         \+                       70                       8085      9.29                                                                                                                                                                 
  orf32       15098--15355         \+                       85                       9657      10.40                                                                                                                                                                
  orf33       15352--15807         \+                      151                       16669     7.75           TMA orf38(46%)                 NC_015937           9e--29    cd01286; COG2131; pfam00383; TIGR02571; PHA02588; TIGR00326; PRK10786       deoxycytidylate deaminase
  orf34       15804--16184         \+                      126                       13761     5.97                                                                                                                                                                 
  orf35       16246--16920         \+                      224                       24092     5.55         IME_AB3 gp46 (35%)               NC_023590           1e--19                                                                                             
  orf36       17087--17476         \+                      129                       14232     8.75         IME_AB3 gp45 (24%)               NC_023590           5e--04                                                                                             
  orf37       17707--18246         \+                      179                       20145     9.34         phiHAP1 gp45 (51%)               NC_010342           2e--48                        pfam05838; pfam09374; COG3926                                        
  orf38       18247--18507         \+                       86                       9810      10.70                                                                                                      PRK12792                                                  
  orf39       18681--19139         \+                      152                       17157     5.35           73 orf5 (37%)                   DQ163913           1e--15                                                                                             
  orf40       19117--20703         \+                      528                       59917     5.90           KL1 orf7 (70%)                 NC_018278             0.0                              TIGR01547; pfam03237                                Terminase large subunit
  orf41       20718--22319         \+                      533                       58562     4.77     vB_PaeKakheti25 orf8 (48%)           NC_017864           5e--151                                 pfam13264                                          Portal protein
  orf42       22316--23350         \+                      344                       38647     8.96           KL1 orf9 (28%)                 NC_018278           6e--37                             TIGR01641; pfam04233                              Head morphogenesis protein
  orf43       23373--24101         \+                      242                       26463     5.57    vB_PaeS_SCH_Ab26 orf9 (46%)           NC_024381            2e-44                             pfam14817; TIGR03345                                   Scaffold protein
  orf44       24156--25133         \+                      325                       35813     5.30         IME_AB3 gp37 (54%)               NC_023590           1e--115                                                                                 Major capsid protein
  orf45       25187--25555         \+                      122                       13033     6.33           73 orf11 (34%)                  DQ163913           3e--04                                                                                             
  orf46       25623--26144         \+                      173                       18469     4.73    vB_PaeS_SCH_Ab26 orf13 (38%)          NC_024381           3e--21                                                                                     Virion protein
  orf47       26141--26539         \+                      132                       14412     8.76                                                                                                                                                                 
  orf48       26547--26999         \+                      150                       17006     8.44          KL1 orf16 (37%)                 NC_018278           6e--16                                                                                   Minor tail protein
  orf49       27010--28644         \+                      544                       58390     4.52    vB_PaeKakheti25 orf17 (46%)           NC_017864           1e--128                                                                                Major tail tube protein
  orf50       28731--29171         \+                      146                       15808     5.67         IME_AB3 gp31 (36%)               NC_023590           2e--24                                                                                     Tail chaperonin
  orf51       29216--29494         \+                       92                       10497     6.54    vB_PaeS_SCH_Ab26 orf18 (40%)          NC_024381           5e--13                                                                                     Tail chaperonin
  orf52       29491--29934         \+                      147                       16064     9.17           73 orf19 (55%)                  DQ163913           8e--42                                                                                             
  orf53       29939--33073         \+                      1044                     110963     6.39          KL1 orf21 (41%)                 NC_018278           3e--142                  TIGR02675; pfam09718; TIGR01541; COG5281                         Tail tape measure
  orf54       33078--34382         \+                      434                       49282     4.46           JWX orf22(35%)                  KP202969           5e--40                                                                                             
  orf55       34387--34839         \+                      150                       15660     9.04          8324 orf21 (43%)                 KP202970           7e--28                                                                                             
  orf56       34870--35967         \+                      365                       36841     7.31                                                                                                                                                                 
  orf57       36005--36544         \+                      179                       20360     5.47           JWX orf25(47%)                  KP202969           1e--46                                  pfam08875                                                  
  orf58       36541--36936         \+                      131                       14701     6.32           JWX orf26(50%)                  KP202969           3e--38                                                                                             
  orf59       36933--40928         \+                      1331                     145652     5.78           JWX orf27(42%)                  KP202969             0.0                         pfam09327; pfam13550; COG4733                            tail component protein
  orf60       40925--41347         \+                      140                       15403     4.62                                                                                                                                                                 
  orf61       41325--41516         \+                       63                       7304      9.43                                                                                                      TIGR03798                                                  
  orf62       41560--43680         −                       706                       80634     7.12         IME_AB3 gp20 (55%)               NC_023590             0.0          cd05538; COG0417; TIGR00592; smart00486; PRK05761; pfam10108            DNA polymerase subunit
  orf63       43680--44720         −                       346                       36538     7.24      vB_PmaS_IMEP1 gp03 (33%)            NC_026608           9e--53                                                                             DNA polymerase III beta subunit
  orf64       44704--45045         −                       100                       11269     8.51    vB_PaeKakheti25 orf29 (48%)           NC_017864           9e--07                                                                                             

^a^amino acids.

###### Virion proteins detected by LC/ESI/MS/MS.

  Protein ID    Score    Mass     Matches    Sequences   emPAI          Annotated Function
  ------------ ------- -------- ----------- ----------- -------- ---------------------------------
  AKJ71391.1     139    61431     13 (6)       8 (5)      0.31       DNA/RNA helicase protein
  AKJ71393.1     63     25248      3 (1)       3 (1)      0.13              recombinase
  AKJ71411.1     15     15384      7 (1)       1 (1)      0.22         hypothetical protein
  AKJ71414.1     15      8056      1 (1)       1 (1)      0.43         hypothetical protein
  AKJ71417.1     265    21030     18 (14)     11 (9)      5.76             endonuclease
  AKJ71360.1     57     24092      3 (3)       2 (2)      0.3          hypothetical protein
  AKJ71365.1     140    59917     17 (11)     14 (10)     0.7         Terminase large subunit
  AKJ71366.1    2203    58562    111 (73)     35 (31)    11.28            Portal protein
  AKJ71369.1    27501   35813    975 (827)    32 (30)    757.42        Major capsid protein
  AKJ71371.1     36     18469      1 (1)       1 (1)      0.18            Virion protein
  AKJ71373.1     16     17006      3 (1)       2 (1)      0.2           Minor tail protein
  AKJ71374.1    7912    58390    378 (269)    31 (31)     40.3        Major tail tube protein
  AKJ71378.1     81     110963     9 (1)       8 (1)      0.03           Tail tape measure
  AKJ71379.1    1146    49282     56 (44)     22 (20)     4.39         hypothetical protein
  AKJ71381.1     245    36841     13 (12)      6 (6)      1.36         hypothetical protein
  AKJ71382.1     30     20360      1 (1)       1 (1)      0.16         hypothetical protein
  AKJ71384.1     53     145652     7 (3)       7 (3)      0.07        tail component protein
  AKJ71388.1     47     36538      5 (1)       4 (1)      0.09    DNA polymerase III beta subunit

[^1]: These authors contributed equally to this work.
